Evidence map›Paper›PMID 21517745›Full record

ReviewRecent patents on biotechnology2011

Plasticity and maintenance of hematopoietic stem cells during development.

Suman Kanji, Vincent J Pompili, Hiranmoy Das

Abstract readReview
In one paragraph

Review in Recent patents on biotechnology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. A Microcavity Array-Based 4D Cell Culture Platform.Bioengineering (Basel, Switzerland) · 2019
    Article
  4. Article
  5. Looking for the elusive lung stem cell niche.Translational respiratory medicine · 2014
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Suman KanjiCardiovascular Stem Cell Research Laboratories, The Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Medical Center, Columbus, Ohio 43210, USA.
Vincent J Pompili
Hiranmoy Das
The Ohio State University Wexner Medical Center · US

Funding

Therapeutic Potential of Ex vivo expanded Human Cord Blood derived CD133+ cells iR44HL092706 · NHLBI · ARTERIOCYTE, INC. · PI COOPER, CHRISTOPHER J, POMPILI, VINCENT J · 2008 to 2011
$2.5M
KLF2 as a novel regular for monocyte activation and functionK01AR054114 · NIAMS · OHIO STATE UNIVERSITY · PI DAS, HIRANMOY · 2008 to 2012
$670k
Novel Markers of Anthracycline-induced Myocardial DamageR21CA143787 · NCI · OHIO STATE UNIVERSITY · PI SHAPIRO, CHARLES L. · 2010 to 2011
$632k
NCI NIH HHS R21 CA143787NHLBI NIH HHS R44 HL092706NHLBI NIH HHS R44 HL092706-01NIAMS NIH HHS K01 AR054114
6 · The paper itself

Abstract

Maintenance of hematopoietic stem cells (HSCs) pool depends on fine balance between self-renewal and differentiation of HSCs. HSCs normally reside within the bone marrow niche of an adult mammal. The embryonic development of HSCs is a complex process that involves the migration of developing HSCs in multiple anatomical sites. Throughout the process, developing HSCs receive internal (transcriptional program) and external (HSC niche) signals, which direct them to maintain balance between self-renewal and differentiation, also to generate a pool of HSCs. In physiological condition HSCs differentiate into all mature cell types present in the blood. However, in pathological condition they may differentiate into non-hematological cells according to the need of the body. It was shown that HSCs can transdifferentiate into cell types that do not belong to the hematopoietic system suggests a complete paradigm shift of the hierarchical hematopoietic tree. This review describes the developmental origins and regulation of HSCs focusing on developmental signals that induce the adult hematopoietic stem cell program, as these informations are very critical for manipulating conditions for expansion of HSCs in ex vivo condition. This review also states clinical application and related patents using HSC.

Indexed as

AnimalsCell DifferentiationCell ProliferationEmbryonic DevelopmentHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansPatents as Topic

Identifiers

PMID21517745
PMCPMC3294454
OpenAlexW2065447929

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.